Stocks in Switzerland

Every company we cover in Switzerland, with intrinsic value and value investing analysis.

28 companies

By sector

• Healthcare (13)

Companies

• NVS - Novartis AG ADR: slightly overvalued, -18% margin of safety
• UBS - UBS Group AG: overvalued, -43% margin of safety
• CB - Chubb Limited: slightly undervalued, +17% margin of safety
• GRMN - Garmin Ltd: undervalued, +33% margin of safety
• STM - ST Microelectronics: overvalued, -68% margin of safety
• ONC - BeOne Medicines Ltd ADR: overvalued, -202% margin of safety
• ALC - Alcon Inc: overvalued, -177% margin of safety
• AMCR - Amcor Plc: undervalued, +36% margin of safety
• LOGI - Logitech International SA: fairly valued, -1% margin of safety
• ONON - On Holding AG: slightly undervalued, +8% margin of safety
• APTV - Aptiv Plc: undervalued, +32% margin of safety
• RIG - Transocean Ltd: not valued
• CRSP - CRISPR Therapeutics AG: overvalued, -203% margin of safety
• SRAD - Sportradar Group AG: undervalued, +78% margin of safety
• VGNT - Versigent Plc: no published value
• SLSR - Solaris Resources Inc: no published value
• MLTX - MoonLake Immunotherapeutics: no published value
• AEBI - Aebi Schmidt Holding AG: not valued
• LAR - Lithium Argentina AG: no published value
• SOPH - SOPHiA Genetics SA: overvalued, -569% margin of safety
• OCS - Oculis Holding AG: no published value
• LAES - SEALSQ Corp: undervalued, +29% margin of safety
• ACIU - AC Immune SA: not valued
• ADCT - Adc Therapeutics SA: slightly overvalued, -5% margin of safety
• VRXA - Veraxa Biotech AG: no published value
• MOLN - Molecular Partners AG ADR: no published value
• NCEL - NewcelX Ltd: no published value
• ADXN - Addex Therapeutics Ltd ADR: overvalued, -3047% margin of safety